Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Epigenetic EGFR gene repression confers sensitivity to therapeutic BRAFV600E blockade in colon neuroendocrine carcinomas.

Capdevila J, Arqués O, Hernandez Mora JR, Matito J, Caratu G, Mancuso FM, Landolfi S, Barriuso J, Jimenez-Fonseca P, Lopez Lopez C, Garcia-Carbonero R, Hernando J, Matos I, Paolo N, Hernández-Losa J, Esteller M, Martínez-Cardús A, Tabernero J, Vivancos A, Palmer HG.

Clin Cancer Res. 2019 Oct 31. pii: clincanres.1266.2019. doi: 10.1158/1078-0432.CCR-19-1266. [Epub ahead of print]

PMID:
31672771
2.

Cerebral Air Embolism after Esophagogastroduodenoscopy: Insight on Pathophysiology, Epidemiology, Prevention and Treatment.

Ghannam M, Beran A, Ghazaleh D, Ferderer T, Berry B, Banna MA, Mohl L, Streib C, Thacker T, Matos I.

J Stroke Cerebrovasc Dis. 2019 Sep 26:104403. doi: 10.1016/j.jstrokecerebrovasdis.2019.104403. [Epub ahead of print]

PMID:
31563566
3.

IDENTIFICATION OF EXPRESSION PROFILES DEFINING DISTINCT PROGNOSTIC SUBSETS OF RADIOACTIVE-IODINE REFRACTORY DIFFERENTIATED THYROID CANCER FROM THE DECISION TRIAL.

Capdevila J, Matos I, Mancuso FM, Iglesias C, Nuciforo P, Zafon C, Palmer HG, Ogbah Z, Muinos L, Hernando J, Villacampa G, Peña CE, Tabernero J, Brose MS, Schlumberger M, Vivancos A.

Mol Cancer Ther. 2019 Sep 20. pii: molcanther.0211.2019. doi: 10.1158/1535-7163.MCT-19-0211. [Epub ahead of print]

PMID:
31540966
4.

Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study).

Solis-Hernandez MP, Fernandez Del Valle A, Carmona-Bayonas A, Garcia-Carbonero R, Custodio A, Benavent M, Alonso Gordoa T, Nuñez-Valdovino B, Sanchez Canovas M, Matos I, Alonso V, Lopez C, Viudez A, Izquierdo M, Calvo-Temprano D, Grande E, Capdevila J, Jimenez-Fonseca P.

Br J Cancer. 2019 Oct;121(7):537-544. doi: 10.1038/s41416-019-0558-7. Epub 2019 Sep 3.

PMID:
31477779
5.

Early evolutionary divergence between papillary and anaplastic thyroid cancers.

Capdevila J, Mayor R, Mancuso FM, Iglesias C, Caratú G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez CV, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J.

Ann Oncol. 2019 Aug 13. pii: mdz216. doi: 10.1093/annonc/mdz216. [Epub ahead of print] No abstract available.

PMID:
31406995
6.

Early-drug development in the era of immuno-oncology: are we ready to face the challenges?

de Olza MO, Oliva M, Hierro C, Matos I, Martin-Liberal J, Garralda E.

Ann Oncol. 2019 Aug 13. pii: mdz211. doi: 10.1093/annonc/mdz211. [Epub ahead of print] No abstract available.

PMID:
31406973
7.

Elevation of the intraocular pressure is associated with focal, topographical decreases in the OCT-A measured microvasculature in glaucoma: A proof-of-concept.

Paula JS, Nakaghi RO, Matos IHO, De Moraes CG.

Clin Exp Ophthalmol. 2019 Aug 1. doi: 10.1111/ceo.13601. [Epub ahead of print] No abstract available.

PMID:
31369183
8.

Immunotherapy in organ-transplanted cancer patients: efficacy and risk of organ rejection.

Ros J, Matos I, Martin-Liberal J.

Ann Oncol. 2019 Jul 1;30(7):1173-1177. doi: 10.1093/annonc/mdz129. No abstract available.

PMID:
30977776
9.

Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials.

Matos I, Noguerido A, Ros J, Mulet N, Argilés G, Elez É, Tabernero J.

Expert Opin Investig Drugs. 2019 May;28(5):463-471. doi: 10.1080/13543784.2019.1599860. Epub 2019 Apr 20. Review.

PMID:
30905200
10.

Hydrogenation of Halogenated 2'-Hydroxychalcones by Mycelia of Marine-Derived Fungus Penicillium raistrickii.

de Matos IL, Nitschke M, Porto ALM.

Mar Biotechnol (NY). 2019 Jun;21(3):430-439. doi: 10.1007/s10126-019-09893-y. Epub 2019 Mar 20.

PMID:
30895403
11.

Allele-specific expression variation at different ploidy levels in Squalius alburnoides.

Matos I, Machado MP, Schartl M, Coelho MM.

Sci Rep. 2019 Mar 6;9(1):3688. doi: 10.1038/s41598-019-40210-8.

12.

Agnostic-Histology Approval of New Drugs in Oncology: Are We Already There?

Hierro C, Matos I, Martin-Liberal J, Ochoa de Olza M, Garralda E.

Clin Cancer Res. 2019 Jun 1;25(11):3210-3219. doi: 10.1158/1078-0432.CCR-18-3694. Epub 2019 Jan 22. Review.

PMID:
30670489
13.

The safety of ramucirumab for the treatment of colorectal cancer.

Noguerido A, Mulet-Margalef N, Matos I, Ros J, Argilés G, Élez E, Tabernero J.

Expert Opin Drug Saf. 2018 Sep;17(9):945-951. doi: 10.1080/14740338.2018.1506762. Epub 2018 Aug 16. Review.

PMID:
30073902
14.

The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.

de Jong SJ, Créquer A, Matos I, Hum D, Gunasekharan V, Lorenzo L, Jabot-Hanin F, Imahorn E, Arias AA, Vahidnezhad H, Youssefian L, Markle JG, Patin E, D'Amico A, Wang CQF, Full F, Ensser A, Leisner TM, Parise LV, Bouaziz M, Maya NP, Cadena XR, Saka B, Saeidian AH, Aghazadeh N, Zeinali S, Itin P, Krueger JG, Laimins L, Abel L, Fuchs E, Uitto J, Franco JL, Burger B, Orth G, Jouanguy E, Casanova JL.

J Exp Med. 2018 Sep 3;215(9):2289-2310. doi: 10.1084/jem.20170308. Epub 2018 Aug 1.

15.

Cr(III) removal from synthetic and industrial wastewaters by using co-gasification chars of rice waste streams.

Dias D, Lapa N, Bernardo M, Ribeiro W, Matos I, Fonseca I, Pinto F.

Bioresour Technol. 2018 Oct;266:139-150. doi: 10.1016/j.biortech.2018.06.054. Epub 2018 Jun 20.

PMID:
29960244
16.

Early-drug development in the era of immuno-oncology: are we ready to face the challenges?

Ochoa de Olza M, Oliva M, Hierro C, Matos I, Martin-Liberal J, Garralda E.

Ann Oncol. 2018 Aug 1;29(8):1727-1740. doi: 10.1093/annonc/mdy225.

PMID:
29945232
17.

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study.

Capdevila J, Teulé A, Barriuso J, Castellano D, Lopez C, Manzano JL, Alonso V, García-Carbonero R, Dotor E, Matos I, Custodio A, Casanovas O, Salazar R; EVERLAR study investigators.

Oncologist. 2019 Jan;24(1):38-46. doi: 10.1634/theoncologist.2017-0622. Epub 2018 May 23.

PMID:
29794066
18.

Early evolutionary divergence between papillary and anaplastic thyroid cancers.

Capdevila J, Mayor R, Mancuso FM, Iglesias C, Caratù G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez CV, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J.

Ann Oncol. 2018 Jun 1;29(6):1454-1460. doi: 10.1093/annonc/mdy123.

PMID:
29648575
19.

Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer.

Mulet N, Matos I, Noguerido A, Martini G, Élez ME, Argilés G, Tabernero J.

Expert Opin Pharmacother. 2018 Apr;19(6):623-629. doi: 10.1080/14656566.2018.1453497. Epub 2018 Mar 28.

PMID:
29537896
20.

Recovery of phenolic compounds from multi-component solution by a synthesized activated carbon using resorcinol and formaldehyde.

Madureira J, Melo R, Verde SC, Matos I, Bernardo M, Noronha JP, Margaça FMA, Fonseca IM.

Water Sci Technol. 2018 Jan;77(1-2):456-466. doi: 10.2166/wst.2017.555.

PMID:
29377830
21.

MuSK myasthenia gravis and pregnancy.

Santos E, Braga A, Gabriel D, Duarte S, Martins da Silva A, Matos I, Freijo M, Martins J, Silveira F, Nadais G, Sousa F, Fraga C, Santos Silva R, Lopes C, Gonçalves G, Pinto C, Sousa Braga J, Leite MI.

Neuromuscul Disord. 2018 Feb;28(2):150-153. doi: 10.1016/j.nmd.2017.11.014. Epub 2017 Nov 28.

PMID:
29305138
22.

The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.

Amair-Pinedo F, Matos I, Saurí T, Hernando J, Capdevila J.

Target Oncol. 2017 Dec;12(6):757-774. doi: 10.1007/s11523-017-0532-3. Review.

PMID:
29143176
23.

Pilot study to evaluate the potential use of the renal resistive index as a preliminary diagnostic tool for chronic kidney disease in cats.

Matos I, Azevedo P, Carreira LM.

J Feline Med Surg. 2018 Oct;20(10):940-947. doi: 10.1177/1098612X17736656. Epub 2017 Oct 30.

PMID:
29082816
24.

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).

Capdevila J, Trigo JM, Aller J, Manzano JL, Adrián SG, Llopis CZ, Reig Ò, Bohn U, Cajal TRY, Duran-Poveda M, Astorga BG, López-Alfonso A, Martínez JM, Porras I, Reina JJ, Palacios N, Grande E, Cillán E, Matos I, Grau JJ.

Eur J Endocrinol. 2017 Oct;177(4):309-317. doi: 10.1530/EJE-17-0243. Epub 2017 Jul 7.

PMID:
28687563
25.

Isolation and Characterization of Yeasts Able to Assimilate Sugarcane Bagasse Hemicellulosic Hydrolysate and Produce Xylitol Associated with Veturius transversus (Passalidae, Coleoptera, and Insecta).

Matos ITSR, Assunção EN, do Carmo EJ, Soares VM, Astolfi-Filho S.

Int J Microbiol. 2017;2017:5346741. doi: 10.1155/2017/5346741. Epub 2017 Jun 6.

26.

Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.

Dienstmann R, Elez E, Argiles G, Matos I, Sanz-Garcia E, Ortiz C, Macarulla T, Capdevila J, Alsina M, Sauri T, Verdaguer H, Vilaro M, Ruiz-Pace F, Viaplana C, Garcia A, Landolfi S, Palmer HG, Nuciforo P, Rodon J, Vivancos A, Tabernero J.

Mol Oncol. 2017 Sep;11(9):1263-1272. doi: 10.1002/1878-0261.12099. Epub 2017 Jul 20.

27.

Anti-inflammatory activity of the essential oil obtained from Ocimum basilicum complexed with β-cyclodextrin (β-CD) in mice.

Rodrigues LB, Martins AOBPB, Ribeiro-Filho J, Cesário FRAS, E Castro FF, de Albuquerque TR, Fernandes MNM, da Silva BAF, Quintans Júnior LJ, Araújo AAS, Menezes PDP, Nunes PS, Matos IG, Coutinho HDM, Goncalves Wanderley A, de Menezes IRA.

Food Chem Toxicol. 2017 Nov;109(Pt 2):836-846. doi: 10.1016/j.fct.2017.02.027. Epub 2017 Feb 22.

28.

Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.

Crespo G, Jiménez-Fonseca P, Custodio A, López C, Carmona-Bayonas A, Alonso V, Navarro M, Aller J, Sevilla I, Grande E, Gajate P, Alonso-Gordoa T, Matos I, Capdevila J, Nieto B, Barriuso J.

Future Oncol. 2017 Mar;13(7):615-624. doi: 10.2217/fon-2016-0434. Epub 2016 Nov 2.

PMID:
27802780
29.

Non-canonical expression patterns and evolutionary rates of sex-biased genes in a seasonal fish.

Machado MP, Matos I, Grosso AR, Schartl M, Coelho MM.

Mol Reprod Dev. 2016 Dec;83(12):1102-1115. doi: 10.1002/mrd.22752. Epub 2016 Nov 4.

PMID:
27770608
30.

Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.

Matos I, Elez E, Capdevila J, Tabernero J.

Expert Opin Emerg Drugs. 2016 Sep;21(3):267-82. doi: 10.1080/14728214.2016.1220535. Epub 2016 Aug 12. Review.

PMID:
27578253
31.

Gene copy silencing and DNA methylation in natural and artificially produced allopolyploid fish.

Matos IM, Coelho MM, Schartl M.

J Exp Biol. 2016 Oct 1;219(Pt 19):3072-3081. Epub 2016 Jul 21.

32.

[Infants' attachment security in a vulnerable French sample].

Tereno S, Guedeney N, Dugravier R, Greacen T, Saïas T, Tubach F, Ulgen S, Matos I, Guédeney A.

Encephale. 2017 Apr;43(2):99-103. doi: 10.1016/j.encep.2015.11.006. Epub 2016 May 20. French.

PMID:
27216594
33.

Nurses knowledge in Transfusion Medicine in a Portuguese university hospital: the impact of an education.

Freixo A, Matos I, Leite A, Silva A, Bischoff F, Carvalho M, Monteiro C, Ferreira A, Fernandes S, Lemos N, Delgado B, Gomes H, Regalado M, Sabio F, Cardoso F, Do Carmo Koch M, Ramos L, Araújo F.

Blood Transfus. 2017 Jan;15(1):49-52. doi: 10.2450/2016.0185-15. Epub 2016 Feb 19. No abstract available.

34.

Molecular Modeling and Physicochemical Properties of Supramolecular Complexes of Limonene with α- and β-Cyclodextrins.

Dos Passos Menezes P, Dos Santos PB, Dória GA, de Sousa BM, Serafini MR, Nunes PS, Quintans-Júnior LJ, de Matos IL, Alves PB, Bezerra DP, Mendonça Júnior FJ, da Silva GF, de Aquino TM, de Souza Bento E, Scotti MT, Scotti L, de Souza Araujo AA.

AAPS PharmSciTech. 2017 Feb;18(1):49-57. doi: 10.1208/s12249-016-0516-0. Epub 2016 Apr 12.

PMID:
27073031
35.

Retain or repel? Droplet volume does matter when measuring leaf wetness traits.

Matos IS, Rosado BH.

Ann Bot. 2016 May;117(6):1045-52. doi: 10.1093/aob/mcw025. Epub 2016 Mar 26.

36.

Nasoethmoidal meningocele in a child presenting bilateral congenital cystic adenomatoid malformation: Evidence for a new entity or consequence of gestational exposures?

da Rosa EB, Silveira DB, Tsugami LG, Bellé NL, Matos IO, Targa LV, Betat Rda S, da Cunha AC, Villacis RA, Rogatto SR, Dorfman LE, Rosa RF, Zen PR.

Birth Defects Res A Clin Mol Teratol. 2016 Apr;106(4):225-31. doi: 10.1002/bdra.23452. Epub 2016 Mar 2.

PMID:
26932830
37.

Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.

Santos E, Coutinho E, Moreira I, Silva AM, Lopes D, Costa H, Silveira F, Nadais G, Morais H, Martins J, Branco MC, Veiga A, Silva RS, Ferreira A, Sousa F, Freijo M, Matos I, André R, Negrão L, Fraga C, Santos M, Sampaio M, Lopes C, Leite MI, Gonçalves G.

Muscle Nerve. 2016 Sep;54(3):413-21. doi: 10.1002/mus.25068. Epub 2016 Jul 4.

PMID:
26851892
38.

WNT-SHH Antagonism Specifies and Expands Stem Cells prior to Niche Formation.

Ouspenskaia T, Matos I, Mertz AF, Fiore VF, Fuchs E.

Cell. 2016 Jan 14;164(1-2):156-169. doi: 10.1016/j.cell.2015.11.058.

39.

Isolation and characterization of yeasts capable of efficient utilization of hemicellulosic hydrolyzate as the carbon source.

Cassa-Barbosa LA, Procópio RE, Matos IT, Filho SA.

Genet Mol Res. 2015 Sep 28;14(3):11605-12. doi: 10.4238/2015.September.28.12.

40.

[SAIMI Study--Health and Health Care Access by Immigrants from the Indian Subcontinent in Lisbon: What Recommendations for Equitable and Culturally Adequate Health Care?].

Matos IC, Alarcão V, Lopes E, Oiko C, Carreira M.

Acta Med Port. 2015 Mar-Apr;28(2):164-76. Epub 2015 May 29. Portuguese.

41.

Corrosion in artificial saliva of a Ni-Cr-based dental alloy joined by TIG welding and conventional brazing.

Matos IC, Bastos IN, Diniz MG, de Miranda MS.

J Prosthet Dent. 2015 Aug;114(2):278-85. doi: 10.1016/j.prosdent.2015.01.017. Epub 2015 Apr 14.

PMID:
25882976
42.

Gene expression dosage regulation in an allopolyploid fish.

Matos I, Machado MP, Schartl M, Coelho MM.

PLoS One. 2015 Mar 19;10(3):e0116309. doi: 10.1371/journal.pone.0116309. eCollection 2015.

43.

Biocatalysis and biotransformation in Brazil: An overview.

Birolli WG, Ferreira IM, Alvarenga N, Santos Dde A, de Matos IL, Comasseto JV, Porto AL.

Biotechnol Adv. 2015 Sep-Oct;33(5):481-510. doi: 10.1016/j.biotechadv.2015.02.001. Epub 2015 Feb 14. Review.

PMID:
25687277
44.

Study of Antiglycation, Hypoglycemic, and Nephroprotective Activities of the Green Dwarf Variety Coconut Water (Cocos nucifera L.) in Alloxan-Induced Diabetic Rats.

Pinto IF, Silva RP, Chaves Filho Ade B, Dantas LS, Bispo VS, Matos IA, Otsuka FA, Santos AC, Matos HR.

J Med Food. 2015 Jul;18(7):802-9. doi: 10.1089/jmf.2014.0046. Epub 2015 Feb 4.

PMID:
25651375
45.

Spatial control of the anaphase-telophase transition.

Afonso O, Matos I, Maiato H.

Cell Cycle. 2014;13(19):2985-6. doi: 10.4161/15384101.2014.959853. No abstract available.

46.

Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. Poit leaves with β-cyclodextrin.

Menezes Pdos P, Araujo AA, Doria GA, Quintans-Junior LJ, de Oliveira MG, dos Santos MR, de Oliveira JF, Matos Jdo R, Carvalho FM, Alves PB, de Matos IL, dos Santos DA, Marreto RN, da Silva GF, Serafini MR.

Curr Pharm Biotechnol. 2015;16(5):440-50.

PMID:
25483719
47.

A chromosome separation checkpoint: A midzone Aurora B gradient mediates a chromosome separation checkpoint that regulates the anaphase-telophase transition.

Maiato H, Afonso O, Matos I.

Bioessays. 2015 Mar;37(3):257-66. doi: 10.1002/bies.201400140. Epub 2014 Dec 3.

PMID:
25470791
48.

Isolated abdominal wall metastasis of endometrial carcinoma.

Luz R, Leal R, Simões J, Gonçalves M, Matos I.

Case Rep Obstet Gynecol. 2014;2014:505403. doi: 10.1155/2014/505403. Epub 2014 Sep 30.

49.

Total and acute uterine inversion after delivery: a case report.

Leal RF, Luz RM, de Almeida JP, Duarte V, Matos I.

J Med Case Rep. 2014 Oct 17;8:347. doi: 10.1186/1752-1947-8-347.

50.

Classical Flt3L-dependent dendritic cells control immunity to protein vaccine.

Anandasabapathy N, Feder R, Mollah S, Tse SW, Longhi MP, Mehandru S, Matos I, Cheong C, Ruane D, Brane L, Teixeira A, Dobrin J, Mizenina O, Park CG, Meredith M, Clausen BE, Nussenzweig MC, Steinman RM.

J Exp Med. 2014 Aug 25;211(9):1875-91. doi: 10.1084/jem.20131397. Epub 2014 Aug 18.

Supplemental Content

Support Center